参赭培气汤联合FOLFOX4化疗方案在晚期肝癌治疗中的价值研究

Research Value of Shenzhe Peiqi Decoction Combined With FOLFOX4 Chemotherapy Regimens in the Treatment of Advanced Liver Cancer

目的探讨参赭培气汤联合FOLFOX4化疗方案治疗晚期肝癌的临床效果。方法 68例晚期肝癌患者随机分为对照组和观察组,各34例。对照组给予FOLFOX4化疗方案治疗,观察组给予参赭培气汤联合FOLFOX4化疗方案治疗。结果两组治疗有效率、毒副反应发生率差异有统计学意义(P<0.05)。结论参赭培气汤联合FOLFOX4化疗方案治疗中晚期肝癌临床效果显著,毒副反应少。

Objective Discuss the effect of Shenzhe Peiqi decoction and FOLFOX4 chemotherapy regimens for treatment of advanced liver cancer. Methods 68 patients with advanced liver cancer were taken as the research object and randomly divided into control group and observation group, 34 cases in each group. Control group was given FOLFOX4 chemotherapy treatment, the observation group was given Shenzhe Peiqi decoction combined FOLFOX4 chemotherapy treatment. Results Two groups had significant treatment efficient and incidence of adverse reaction（P〈0. 05）. Conclusion Shenzhe Peiqi decoction combined with FOLFOX4 chemotherapy regimen for locally advanced hepatocellular carcinoma have less adverse reaction.